KALA BIO, Inc. — Form D

KALA BIO, Inc. of ARLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-17. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Chaim BergerDirectorArlington, MA
Yonatan ColmanDirectorArlington, MA
Avi MinkowitzDirectorArlington, MA
Hillel PosenDirectorArlington, MA
Brendan PurdyDirectorArlington, MA
Avi MinkowitzExecutive OfficerArlington, MA
Robert LangerDirectorPittsburgh, PA
Kevin BittermanDirectorCambridge, MA
Andrew L KovenDirectorCambridge, MA
David LazarDirectorARLINGTON, MA
Darius KharabiExecutive OfficerArlington, MA
Todd BazemoreExecutive OfficerFRAMINGHAM, MA
Gregory D PerryDirectorArlington, MA
Marjan D FaridDirectorArlington, MA
Mark IwickiDirectorArlington, MA
Mark IwickiExecutive OfficerArlington, MA
Mary ReumuthExecutive OfficerArlington, MA
C. Daniel MyersDirectorArlington, MA
Kim BrazzellExecutive OfficerArlington, MA
Mark S BlumenkranzDirectorArlington, MA
PETER COUROSSIExecutive OfficerChicago, IL
Howard B RosenDirectorSan Mateo, CA
Robert TepperDirectorCambridge, MA
Greg GrunbergDirectorLawrence, MA
Darius Daniel KharabiExecutive OfficerWatertown, MA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-02-13D$4.2M$2.3M
2024-12-31D$10.7M$10.7M
2024-06-28D$12.5M$12.5M
2021-11-29D$36.5M$16.1M
2016-04-13D$67.9M$67.9M
2015-08-19D$7.0M$7.0M
2014-04-24D$22.5M$22.5M
2013-02-28D$11.5M$5.8M
2012-03-14D$7.2M$7.2M
2010-11-10D$3.0M$3.0M
2009-12-23D$2.0M$2.0M

More